Olprima EPA|DHA provides condition-specific support through a 55:45 ratio of the omega-3s, EPA and DHA. Olprima EPA|DHA supports cardiovascular and brain health while supporting the body’s healthy inflammatory response.*
- Supports cardiovascular health*^
- Supports healthy inflammatory processes*
- Supports general brain health and cognition*
- General mood support
^ As part of a diet low in saturated fat and cholesterol.
Dyall, S.C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci 7, 52 (2015).
Allaire, J., et al. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study. Am J Clin Nutr 104, 280-287 (2016).
Martins, J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28, 525-542 (2009).
Suggested Use: Two softgels per day, or as directed.
|Serving Size: 2 Softgels
Servings per Container: 30
|Amount per Serving %Daily Value|
*Percent Daily Values are based on a 2,000 calorie diet.
†Daily Value not established.
Other ingredients: Gelatin, water, glycerine, rosemary, and astaxanthin.
Caution: This product is processed in a facility that manufactures other products containing soy, milk, egg, wheat, peanut, tree nuts, fish, and shellfish.
Please consult the actual product label for the most accurate product information.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.